Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient

Multi-system inflammatory syndrome in children associated with COVID19 (MIS-C) is a unique clinical syndrome characterised by fever, gastrointestinal symptoms, skin and oral rash and or neurological symptoms in the presence of raised acute phase reactants and coagulopathy. Ferritin is an acute phase...

Full description

Saved in:
Bibliographic Details
Main Authors: Swarnalata Das, Manas Behera Ranjan, Palash Das
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:https://journals.lww.com/10.4103/ajts.ajts_112_21
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593745327947776
author Swarnalata Das
Manas Behera Ranjan
Palash Das
author_facet Swarnalata Das
Manas Behera Ranjan
Palash Das
author_sort Swarnalata Das
collection DOAJ
description Multi-system inflammatory syndrome in children associated with COVID19 (MIS-C) is a unique clinical syndrome characterised by fever, gastrointestinal symptoms, skin and oral rash and or neurological symptoms in the presence of raised acute phase reactants and coagulopathy. Ferritin is an acute phase reactant which is used as a marker of inflammation. Diagnosis of MIS-C in the background of transfusion dependent thalassemia with iron overload needs a strong clinical suspicion. Early diagnosis and prompt treatment are necessary to ensure a rapid uneventful recovery. A three-year-old male child born to non-consanguineously related parents reported to pediatric emergency with difficulty breathing and pain abdomen for one day. The child was a diagnosed case of Beta thalassemia major since the age of one year and was on regular transfusions and was on iron chelation for past eleven months with deferrasirox. Initial clinical examination showed a sick and irritable child with tachypnea tachycardia and hypoxia. Initial investigations showed raised acute phase reactants along with severe anemia. The child was investigated for MIS-C because of unexpected rise of serum ferritin from 1980 ng/mL (October 2020) to 6686 ng/mL (in January 2021) despite being on regular chelation. Antibody titre for SARS COVID-19 was positive. The patient was treated with intravenous corticosteroids and improved with the same. The advent of COVID19 pandemic saw most children having a mild disease with no or minimal symptoms. Some kids however presented with more serious delayed symptoms of MIS-C. To diagnose same in multi transfused patients a strong clinical suspicion and just judgement based on the clinical and laboratory findings should be done. Unexplained rise in ferritin levels, typical symptoms and high probability of exposure to COVID19 helped in clinching diagnosis.
format Article
id doaj-art-f418fc4765604e2bb65e1df6e1cf145a
institution Kabale University
issn 0973-6247
1998-3565
language English
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj-art-f418fc4765604e2bb65e1df6e1cf145a2025-01-20T09:40:42ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652024-01-0118113814010.4103/ajts.ajts_112_21Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patientSwarnalata DasManas Behera RanjanPalash DasMulti-system inflammatory syndrome in children associated with COVID19 (MIS-C) is a unique clinical syndrome characterised by fever, gastrointestinal symptoms, skin and oral rash and or neurological symptoms in the presence of raised acute phase reactants and coagulopathy. Ferritin is an acute phase reactant which is used as a marker of inflammation. Diagnosis of MIS-C in the background of transfusion dependent thalassemia with iron overload needs a strong clinical suspicion. Early diagnosis and prompt treatment are necessary to ensure a rapid uneventful recovery. A three-year-old male child born to non-consanguineously related parents reported to pediatric emergency with difficulty breathing and pain abdomen for one day. The child was a diagnosed case of Beta thalassemia major since the age of one year and was on regular transfusions and was on iron chelation for past eleven months with deferrasirox. Initial clinical examination showed a sick and irritable child with tachypnea tachycardia and hypoxia. Initial investigations showed raised acute phase reactants along with severe anemia. The child was investigated for MIS-C because of unexpected rise of serum ferritin from 1980 ng/mL (October 2020) to 6686 ng/mL (in January 2021) despite being on regular chelation. Antibody titre for SARS COVID-19 was positive. The patient was treated with intravenous corticosteroids and improved with the same. The advent of COVID19 pandemic saw most children having a mild disease with no or minimal symptoms. Some kids however presented with more serious delayed symptoms of MIS-C. To diagnose same in multi transfused patients a strong clinical suspicion and just judgement based on the clinical and laboratory findings should be done. Unexplained rise in ferritin levels, typical symptoms and high probability of exposure to COVID19 helped in clinching diagnosis.https://journals.lww.com/10.4103/ajts.ajts_112_21case reportchildcovid-19ferritinmultisystem inflammatory syndrome in childrenthalassemia
spellingShingle Swarnalata Das
Manas Behera Ranjan
Palash Das
Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
Asian Journal of Transfusion Science
case report
child
covid-19
ferritin
multisystem inflammatory syndrome in children
thalassemia
title Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
title_full Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
title_fullStr Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
title_full_unstemmed Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
title_short Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
title_sort multisystem inflammatory syndrome in children with covid 19 in a multitransfused patient
topic case report
child
covid-19
ferritin
multisystem inflammatory syndrome in children
thalassemia
url https://journals.lww.com/10.4103/ajts.ajts_112_21
work_keys_str_mv AT swarnalatadas multisysteminflammatorysyndromeinchildrenwithcovid19inamultitransfusedpatient
AT manasbeheraranjan multisysteminflammatorysyndromeinchildrenwithcovid19inamultitransfusedpatient
AT palashdas multisysteminflammatorysyndromeinchildrenwithcovid19inamultitransfusedpatient